skip to content
Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines Preview this item
ClosePreview this item
Checking...

Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Author: Canadian Agency for Drugs and Technologies in Health,
Publisher: [Ottawa] : Canadian Agency for Drugs and Technologies in Health, 10 February 2015.
Series: Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Edition/Format:   eBook : Document : National government publication : English
Summary:
Invasive meningococcal disease (IMD) is a potentially life threatening infectious disease caused by the gram-negative aerobic diplococcus, Neisseria (N.) meningitidis. Transmission of N. meningitidis occurs through respiratory droplets or direct contact with nasopharyngeal secretions while the usual incubation period is 3 to 4 days. To limit the spread of IMD, chemoprophylaxis with or without immunoprophylaxis is  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Review
Material Type: Document, Government publication, National government publication, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Canadian Agency for Drugs and Technologies in Health,
OCLC Number: 904787049
Notes: Title from PDF caption.
"CADTH rapid response service."
Description: 1 online resource (1 PDF file (7 pages)).
Series Title: Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Other Titles: Prophylactic treatment for contacts of patients with IMD on sports teams
Responsibility: prepared by Canadian Agency for Drugs and Technologies in Health.

Abstract:

Invasive meningococcal disease (IMD) is a potentially life threatening infectious disease caused by the gram-negative aerobic diplococcus, Neisseria (N.) meningitidis. Transmission of N. meningitidis occurs through respiratory droplets or direct contact with nasopharyngeal secretions while the usual incubation period is 3 to 4 days. To limit the spread of IMD, chemoprophylaxis with or without immunoprophylaxis is offered to contacts with the goal of eliminating N. meningitidis from the nasopharynx of contacts within the case's network. Contacts with ongoing exposure to the case usually require both chemoprophylaxis and immunoprophylaxis. The exposure risk that arises from playing on a sports team presents some unique challenges in the event a team member becomes diagnosed with IMD. Members of a sports team typically share water bottles, locker room facilities, and travel together; in addition, players may come into direct contact with oral and nasal secretions during the course of play. The purpose of this review was to assess the evidence of the clinical effectiveness and cost-effectiveness of prophylactic treatment for contacts of patients with invasive meningococcal disease (IMD) who are members of sports teams, and to identify and appraise any relevant evidence-based guidelines.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/904787049> # Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines
    a schema:CreativeWork, schema:Book, schema:MediaObject ;
    library:oclcnum "904787049" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/onc> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/2465080191#Topic/cost_benefit_analysis> ; # Cost-Benefit Analysis
    schema:about <http://experiment.worldcat.org/entity/work/data/2465080191#Topic/meningococcal_infections_immunology> ; # Meningococcal Infections--immunology
    schema:about <http://experiment.worldcat.org/entity/work/data/2465080191#Topic/practice_guidelines_as_topic> ; # Practice Guidelines as Topic
    schema:about <http://experiment.worldcat.org/entity/work/data/2465080191#Topic/athletes> ; # Athletes
    schema:about <http://experiment.worldcat.org/entity/work/data/2465080191#Topic/chemoprevention> ; # Chemoprevention
    schema:about <http://experiment.worldcat.org/entity/work/data/2465080191#Topic/treatment_outcome> ; # Treatment Outcome
    schema:about <http://experiment.worldcat.org/entity/work/data/2465080191#Topic/meningococcal_infections_prevention_&_control> ; # Meningococcal Infections--prevention & control
    schema:alternateName "Prophylactic treatment for contacts of patients with IMD on sports teams" ;
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/2465080191#Organization/canadian_agency_for_drugs_and_technologies_in_health> ; # Canadian Agency for Drugs and Technologies in Health,
    schema:datePublished "2015" ;
    schema:description "Invasive meningococcal disease (IMD) is a potentially life threatening infectious disease caused by the gram-negative aerobic diplococcus, Neisseria (N.) meningitidis. Transmission of N. meningitidis occurs through respiratory droplets or direct contact with nasopharyngeal secretions while the usual incubation period is 3 to 4 days. To limit the spread of IMD, chemoprophylaxis with or without immunoprophylaxis is offered to contacts with the goal of eliminating N. meningitidis from the nasopharynx of contacts within the case's network. Contacts with ongoing exposure to the case usually require both chemoprophylaxis and immunoprophylaxis. The exposure risk that arises from playing on a sports team presents some unique challenges in the event a team member becomes diagnosed with IMD. Members of a sports team typically share water bottles, locker room facilities, and travel together; in addition, players may come into direct contact with oral and nasal secretions during the course of play. The purpose of this review was to assess the evidence of the clinical effectiveness and cost-effectiveness of prophylactic treatment for contacts of patients with invasive meningococcal disease (IMD) who are members of sports teams, and to identify and appraise any relevant evidence-based guidelines."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/2465080191> ;
    schema:genre "Review"@en ;
    schema:genre "Government publication"@en ;
    schema:genre "National government publication"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://worldcat.org/issn/1922-8147> ; # Rapid response report (Canadian Agency for Drugs and Technologies in Health)
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/2465080191#Series/rapid_response_report_summary_with_critical_appraisal> ; # Rapid response report: summary with critical appraisal
    schema:name "Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines"@en ;
    schema:productID "904787049" ;
    schema:url <https://www.ncbi.nlm.nih.gov/books/NBK274356> ;
    schema:url <http://www.ncbi.nlm.nih.gov/books/NBK274356/> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/904787049> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/2465080191#Organization/canadian_agency_for_drugs_and_technologies_in_health> # Canadian Agency for Drugs and Technologies in Health,
    a schema:Organization ;
    schema:name "Canadian Agency for Drugs and Technologies in Health," ;
    .

<http://experiment.worldcat.org/entity/work/data/2465080191#Series/rapid_response_report_summary_with_critical_appraisal> # Rapid response report: summary with critical appraisal
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/904787049> ; # Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines
    schema:name "Rapid response report: summary with critical appraisal" ;
    .

<http://experiment.worldcat.org/entity/work/data/2465080191#Topic/cost_benefit_analysis> # Cost-Benefit Analysis
    a schema:Intangible ;
    schema:name "Cost-Benefit Analysis"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2465080191#Topic/meningococcal_infections_immunology> # Meningococcal Infections--immunology
    a schema:Intangible ;
    schema:name "Meningococcal Infections--immunology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2465080191#Topic/meningococcal_infections_prevention_&_control> # Meningococcal Infections--prevention & control
    a schema:Intangible ;
    schema:name "Meningococcal Infections--prevention & control"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2465080191#Topic/practice_guidelines_as_topic> # Practice Guidelines as Topic
    a schema:Intangible ;
    schema:name "Practice Guidelines as Topic"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2465080191#Topic/treatment_outcome> # Treatment Outcome
    a schema:Intangible ;
    schema:name "Treatment Outcome"@en ;
    .

<http://worldcat.org/issn/1922-8147> # Rapid response report (Canadian Agency for Drugs and Technologies in Health)
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/904787049> ; # Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines
    schema:issn "1922-8147" ;
    schema:name "Rapid response report (Canadian Agency for Drugs and Technologies in Health)" ;
    .

<http://www.worldcat.org/title/-/oclc/904787049>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/904787049> ; # Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines
    schema:dateModified "2018-01-08" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.